Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study

BACKGROUND: Neuroendocrine carcinoma (NEC) is a rare and highly malignant variation of prostate adenocarcinoma. We aimed to investigate the prognostic value of NEC in prostate cancer. METHODS: A total of 530440 patients of prostate cancer, including neuroendocrine prostate cancer (NEPC) and adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiping, Liu, Yanning, Liang, Xue, Shao, Jiajia, Zhang, Yina, Yang, Jing, Zheng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692830/
https://www.ncbi.nlm.nih.gov/pubmed/34956090
http://dx.doi.org/10.3389/fendo.2021.778758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692830/
https://www.ncbi.nlm.nih.gov/pubmed/34956090
http://dx.doi.org/10.3389/fendo.2021.778758

Ejemplares similares